Substitute House Bill No. 7022 mandates the Commissioner of Social Services to amend the Medicaid state plan to include coverage for fertility diagnostic care, fertility preservation services, and fertility treatment. This includes coverage for medically necessary ovulation-enhancing drugs and related medical services, as well as a minimum of three cycles of ovulation-enhancing medication treatment. The bill defines "infertility" based on various medical conditions and circumstances affecting an individual's ability to conceive. It also requires that fertility preservation services be provided to individuals with medical conditions or those undergoing treatments that may impair fertility, including the procurement and cryopreservation of gametes and embryos, with a storage requirement of at least five years or until the individual reaches age 30.

Furthermore, the bill mandates that by July 1, 2026, the Commissioner must report to the Appropriations and Human Services committees on the costs and benefits of including in-vitro fertilization (IVF) as a covered benefit under Medicaid, addressing potential Medicaid waivers and financial implications for the state. The bill is set to take effect on January 1, 2026, and aims to promote equity in Medicaid coverage for fertility health care. While the new legal language emphasizes the importance of fertility services in Medicaid coverage, no specific deletions from current law are noted in the summary provided. The Human Services Committee has favorably reported the bill with a vote of 16 in favor and 6 against.